marginally significantP ‐value = 0.056
Among the 20 comparisons made, significant differences in BMD were observed between the Beta‐adrenergic Blockers and four drug categories ( Figure 7 ), while the difference between the Antiplatelet Drugs and Beta‐adrenergic Blockers was marginally significant (OR = 1.15, 95% CI 1–1.32, P ‐value = 0.056).